Table 2. Variables Facilitating a Safer Disclosure in Individuals With SCD+ and Amyloid-Positive Results.
| Features | IES-R | Changes in HADS | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total | Avoidance | Intrusions | Hyperarousal | Anxiety | Depression | |||||||
| Index, W | P value | Index, W | P value | Index, W | P value | Index, W | P value | Index, W | P value | Index, W | P value | |
| Age (y), ρ | –0.15 | .45 | –0.16 | .44 | –0.19 | .35 | 0.07 | .73 | –0.02 | .91 | –0.25 | .23 |
| Gender | 92.0 | .98 | 91.5 | 1.00 | 102.0 | .61 | 70.5 | .32 | 85.5 | .98 | 106.5 | .26 |
| Education (years), ρ | –0.18 | .37 | –0.13 | .51 | –0.07 | .73 | –0.43 | .02 | –0.15 | .48 | –0.15 | .46 |
| MMSE, ρ | 0.21 | .29 | 0.35 | .07 | –0.01 | .95 | 0.04 | .83 | 0.23 | .26 | –0.10 | .61 |
| Communication that SCD+ is a risk condition | 1.5 | .16 | 6.5 | .41 | 2.0 | .17 | 3.5 | .24 | 14.0 | .89 | 18.0 | .50 |
| Disclosure type (face to face vs phone) |
72.0 | .30 | 64.5 | .54 | 68.5 | .41 | 65.0 | .55 | 51.0 | .64 | 27.0 | .23 |
| Disclosure duration (min), ρ | 0.02 | .93 | 0.16 | .44 | 0.03 | .90 | –0.31 | .13 | –0.28 | .18 | –0.27 | .19 |
| Presence of study partner | 7.5 | .03 | 21.0 | .23 | 11.5 | .06 | 15.0 | .11 | 49.0 | .26 | 24.0 | .41 |
Abbreviations: HADS, Hospital Anxiety and Depression scale; IES-R, Impact of Events Scale–Revised; MMSE, Mini Mental State Examination; SCD+, subjective cognitive decline plus.